Vaginitis and STIs: The right treatment begins with the right diagnosis

Learn more about how the BD Vaginal Panel and the BD CTGCTV2 assay can help decrease the number of recurrent visits, incorrect treatments and negative sequelae associated with vaginits and STIs.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

FiercePharma
New BD survey finds nearly half of women unaware of STI treatment options
BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Specimen Collection for the BD Vaginal Panel
Vaginitis | Webinars & Videos
Specimen Collection for the BD Vaginal Panel